Article

Absence of CD47 in the tumor microenvironment modulates tumor metabolism and immunosuppressive signatures limiting breast cancer progression

2023-07-14

Abstract excerpt

The majority of breast cancers are generally considered immune-deprived tumors. This lack of immunogenicity severely hinders effectiveness of current immunotherapy approaches limiting therapeutic options to control disease. Therefore, we need new biomarkers to determine and enhance immune responses to improve the outcome of cancer patients experiencing invasive disease. Our data in matched human patient biopsies s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ad306c8c-8343-5b6d-ac13-7412fb388318
DOI: 10.1101/2023.07.12.548766

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Absence of CD47 in the tumor microenvironment modulates tumor metabolism and immunosuppressive signatures limiting breast cancer progressionDOI 10.1101/2023.07.12.548766Read

Anti-CD47 immunotherapy as a therapeutic strategy for the treatment of breast cancer brain metastasisSemantic proximity Read

A multidimensional pan-cancer analysis of CD47 and its role in promoting malignant phenotype in pancreatic adenocarcinoma.Semantic proximity Read

Role of CD47 in tumor immunity: a potential target for combination therapySemantic proximity Read

CD47 Receptor Globally Regulates Metabolic Pathways That Control Resistance to Ionizing RadiationSemantic proximity Read

CD147‑mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review)Semantic proximity Read

Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.Semantic proximity Read

CD47 promotes mitogen-activated protein kinase and epithelial-to-mesenchymal transition molecular programs to drive prometastatic phenotypes in non-small cell lung cancer.Semantic proximity Read

Targeting CD47: the achievements and concerns of current studies on cancer immunotherapySemantic proximity Read

Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα AxisSemantic proximity Read

An immune-stimulating antibody conjugate spatiotemporally targeting CD47 and TLR9 elicits macrophage-dependent tumor clearance and durable anti-cancer adaptive immunitySemantic proximity Read

Isoform switching of CD47 induces macrophage-initiated cancer cell pyroptosisSemantic proximity Read

Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1αSemantic proximity Read